Revving up a process that slows down as we age may protect against atherosclerosis, a major cause of heart attacks and strokes. In findings published online today in Proceedings of the National Academy of Sciences (PNAS), ...
Mar 28, 2022
0
535
The World Trade Organization chief on Wednesday hailed a breakthrough between the EU, the United States, India and South Africa on waiving intellectual property rights on COVID-19 vaccines.
Mar 16, 2022
0
8
Pharmaceutical company Moderna announced on 7 March 2022 that it would develop a site in Kenya to manufacture COVID-19 vaccines. The company holds much of the key intellectual property relating to the messenger RNA (mRNA) ...
Mar 14, 2022
0
15
Researchers at Michigan Medicine have found a novel method of measuring growth in the body's largest artery that may help clinicians to identify potentially fatal heart conditions earlier.
Feb 16, 2022
0
10
In an interconnected world, a pandemic can be overcome only when it is overcome everywhere—no one is safe until everyone is safe. Vaccination delays and supply shortages in protective equipment and treatments increase the ...
Feb 15, 2022
0
6
The EU on Monday stood by its refusal to lift patent protections on COVID vaccines, just days ahead of a summit with African Union countries who see the issue as a priority.
Feb 14, 2022
0
2
Many cases of early prostate cancer are dominated by cells that are slow-growing, often leading to a clinical decision to monitor for progression before initiating treatments that can have adverse side effects.
Jan 19, 2022
0
0
Over a year into global COVID-19 vaccination efforts the question of whether jab formulas ought to be freely available is still unresolved—and undersupplied countries are turning to workarounds.
Jan 17, 2022
0
19
The emergence of the Omicron variant of the coronavirus is the "ultimate evidence" of the danger of unequal vaccination rates around the world, the head of the Red Cross said on Friday.
Dec 3, 2021
0
23
South African pharma giant Aspen said Tuesday it has reached an agreement in principle with US-based Johnson & Johnson paving the way for an anti-COVID vaccine "made in Africa for Africa".
Nov 30, 2021
0
3
